Obstructive Jaundice Features
Obstructive jaundice presents with conjugated hyperbilirubinemia, elevated alkaline phosphatase (typically >2-4x normal), dilated bile ducts on imaging, and clinically manifests as jaundice, pruritus, dark urine, and pale stools. 1
Clinical Presentation
The hallmark clinical features include:
- Jaundice (yellowing of skin and sclera) - visible when serum bilirubin exceeds 2.5-3 mg/dL 2
- Pruritus (itching) - often severe and precedes visible jaundice 3
- Dark urine (tea-colored) from conjugated bilirubinuria 4
- Acholic (pale/clay-colored) stools from absent bile pigments 4
- Right upper quadrant pain - particularly with choledocholithiasis 5, 6
- Intermittent fevers - suggests cholangitis (Charcot's triad when combined with jaundice and RUQ pain) 5
Important caveat: Asymptomatic presentation strongly suggests malignant obstruction rather than benign causes 4. The mean duration of symptoms at presentation is often prolonged (8+ weeks), indicating delayed diagnosis 6.
Laboratory Features
Conjugated (Direct) Hyperbilirubinemia Pattern
The key distinguishing feature is conjugated bilirubin elevation, differentiating obstructive from hepatocellular causes 1, 7.
Enzyme Patterns - Critical Nuance
Contrary to conventional teaching, the enzyme pattern varies by etiology:
- Malignant strictures: Alkaline phosphatase rises MORE than AST (ALP 4.3x normal vs AST 2.6x normal) 8
- Choledocholithiasis: AST may equal or EXCEED ALP elevation, particularly during:
This is a critical pitfall: Clinicians must consider biliary obstruction even when AST is the predominantly elevated enzyme, especially in stone disease 8.
Standard Laboratory Panel
Initial evaluation requires 2, 7:
- Fractionated bilirubin (conjugated vs unconjugated)
- Alkaline phosphatase - typically elevated >2x normal 3
- γ-glutamyltransferase (GGT) - confirms hepatobiliary origin of elevated ALP 3
- AST and ALT - variable elevation
- Prothrombin time/INR - assesses synthetic function; abnormal in advanced disease 3
- Serum albumin - decreased only in advanced/chronic obstruction 3
- Complete blood count - evaluates for infection/hemolysis 7
Additional Markers in Specific Contexts
For suspected primary biliary cirrhosis (a cholestatic disorder):
- Antimitochondrial antibodies (AMA) - positive in >90% of PBC cases 3
- Elevated IgM - typical in PBC 3
- Serum cholesterol - commonly elevated in all cholestatic conditions 3
Imaging Features
Initial Imaging Algorithm
Abdominal ultrasound is the mandatory first-line imaging modality 3, 1. It differentiates intrahepatic from extrahepatic cholestasis with:
Ultrasound Findings
Positive findings:
- Dilated intrahepatic and/or extrahepatic bile ducts - the defining feature 1
- Common bile duct >6mm (>10mm post-cholecystectomy) 1
- May identify obstruction site and etiology (stones, masses) 1
Limitations:
- Cannot visualize distal CBD in 25-78% due to bowel gas 1
- Sensitivity for CBD stones only 22.5-75% 1
- False negatives occur in early/acute obstruction before ductal dilation develops 1
Advanced Imaging When Needed
MRCP (Magnetic Resonance Cholangiopancreatography) is the next step for:
- Unexplained cholestasis after ultrasound 3
- Better visualization of biliary anatomy (sensitivity 77-88% for CBD stones) 1
- Non-invasive alternative to ERCP 3
CT abdomen can demonstrate:
- Site and cause of obstruction 1
- Pancreatic or periampullary masses
- Less sensitive than MRCP for small stones 1
Common Etiologies by Frequency
The differential varies by geography and setting, but includes 1:
Malignant causes (most common in severe jaundice):
- Pancreatic adenocarcinoma
- Cholangiocarcinoma
- Ampullary tumors
- Metastatic disease
Benign causes:
- Choledocholithiasis (CBD stones) - 13-14% of cases 1
- Primary sclerosing cholangitis
- Chronic pancreatitis with stricture
- Post-procedural strictures
Critical age consideration: Patients <50 years have the SAME likelihood of malignancy as those >50 years, requiring equal vigilance 6.
Diagnostic Pitfalls to Avoid
Don't dismiss biliary obstruction when AST > ALP - this pattern occurs commonly with choledocholithiasis 8
Normal CBD caliber on ultrasound has 95-96% negative predictive value - but early/intermittent obstruction may not show dilation 1
Asymptomatic presentation = think malignancy until proven otherwise 4
ERCP should be reserved for therapeutic intervention, not diagnosis - use MRCP or EUS for diagnostic evaluation due to ERCP's 5-10% complication rate and 0.1-1% mortality 3, 1
Multiple small gallstones (<5mm) create 4-fold risk for CBD migration - maintain high suspicion even with negative initial imaging 1